Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
about
Subversion of Host Innate Immunity by Uropathogenic Escherichia coliMechanisms of pain from urinary tract infectionStrong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells.Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women.Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infectionPolysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.Escherichia coli global gene expression in urine from women with urinary tract infection.Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta transcriptional response in vitro.Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.Lipid isolated from a Leishmania donovani strain reduces Escherichia coli induced sepsis in mice through inhibition of inflammatory responsesLactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4.The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urineTLR-based immune adjuvants.Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infectionGlobal gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tractInnate immunity and genetic determinants of urinary tract infection susceptibility.Characterization of Toll-like receptor-4 (TLR-4) in the spleen and thymus of Swiss albino mice and its modulation in experimental endotoxemia.Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells.TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladderMellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection.Emerging drugs for bacterial urinary tract infections.A Murine Model for Escherichia coli Urinary Tract Infection.Regulation of surfactant protein D in the rodent prostate.Profibrotic effect of interleukin-18 in HK-2 cells is dependent on stimulation of the Toll-like receptor 4 (TLR4) promoter and increased TLR4 expression.Septic acute kidney injury: molecular mechanisms and the importance of stratification and targeting therapy.Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammationMolecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Uropathogenic E. coli promote a paracellular urothelial barrier defect characterized by altered tight junction integrity, epithelial cell sloughing and cytokine release.TLR-mediated immune responses in the urinary tract.The innate immune response during urinary tract infection and pyelonephritis.
P2860
Q26770272-1161E53D-7BCE-4625-A849-B1FDD3C4C370Q27028174-DD747D85-782B-4B2D-BBAD-BEE2D587902FQ33211484-F1EE7202-38E1-4448-B479-83B91D14FA15Q33283062-98AF4031-DE3F-49F8-90F7-2E85BFCCE312Q33471464-B3976138-704E-4FAE-ABC3-53B847068B79Q33588560-D5408279-7D28-4FB9-9472-09FF7183EA41Q33652449-06BCF53A-D237-4613-85DE-4A481F3165BDQ33675852-00091E63-56C6-4245-A87B-F8795C3375CCQ33707731-5C6ECB9B-3F54-4DE5-B054-05515948D057Q33750030-89A0C0ED-362C-488B-BA0A-A0782700A10BQ33769920-6A3A8998-6375-427F-935C-7750DC28DD8CQ33883358-264458DE-1238-457E-8F0D-7C72DF7D0B70Q33998530-B451AA77-762E-4800-95BD-119A5190CF4EQ34134619-8664D7CD-B01E-4A4E-8FAE-0A2CD9CE9355Q34301103-F7D223A9-584D-45B3-B143-B08F86B88B53Q34400322-372C48CD-6985-466F-9167-AB82C06CE6D4Q34552745-A6A1C96A-5CDD-4631-8D44-86A4DEF1C76BQ34646648-4909637F-5482-4764-B362-5D83AD77F611Q34681070-3189DE75-B5C2-4FFE-AA97-08A58DED7458Q34856462-75293C8A-5834-4F47-B006-8ECD56C71DE6Q35156132-8450F9AC-61A7-436D-B1E3-DACFA224EA71Q35197365-1033B7E4-C311-4BF7-AD84-3B33C79EFACBQ35852635-B18F9635-5D44-42DE-873D-92FA84CCF810Q35860382-857B2E2D-8A9E-42A8-BD8F-0CCCAAB7E988Q35944364-7E14126A-49E6-443B-85DB-1AE441621E55Q35949736-048B36DF-3C5F-44DA-AF1D-69365E1D30AFQ36091814-A39D111E-7D14-44DC-B43B-EAAC1DCDB06BQ36150606-1F200A84-BDAC-4A77-BAA9-837099814856Q36219597-52F8738A-3C7C-4933-8E4D-EE5934FBD2FAQ36389346-72BB31C2-B388-4341-BCB7-8095F4C6FB25Q36418829-0242C0A2-BE1A-4F82-BF5E-A7172E0B4369Q36508860-0161D6DD-7038-486C-AA98-258B13840974Q36634934-4C2950B9-4C2F-4768-B090-0DF2B40EABE5Q36732312-3C70E1D2-B0B3-4AD6-98BC-78F0633A9E9BQ36845149-9F8F59B2-C67F-4DA2-AE5F-248FC757A3CAQ36903028-E81A20C7-ACD4-4685-AE45-30C0FBFEAD6CQ36910650-9D440CCA-6B0B-4850-AEDF-8E5FB8E25AE1Q36964454-64169A7D-E013-4C81-9A16-CCBC8F9C2519Q37074933-D6F0CAE6-407A-40FF-BF63-E422E9F1E373Q37238866-135D001F-27AE-4DC3-B391-71283E30F17A
P2860
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
@en
type
label
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
@en
prefLabel
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
@en
P2093
P2860
P1476
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
@en
P2093
Björn Wullt
Catharina Svanborg
Heikki Irjala
Patrik Samuelsson
P2860
P304
P356
10.1128/IAI.72.6.3179-3186.2004
P407
P577
2004-06-01T00:00:00Z